Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Short-acting tablet that boosts insulin release in type 2 diabetes. | Sulfonylurea that boosts insulin release. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Sulfonylureas | Sulfonylureas |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Type 2 diabetes | Type 2 diabetes |
| How it works | Encourages the pancreas to release more insulin after meals. | Tells your pancreas to release more insulin. |
| Starts working | — | — |
| Half-life | — | 10–12 hours |
| Typical adult dose | Usually starts at 2.5–5 mg before breakfast; increase carefully according to glucose readings. | 40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast. |
| Forms | Tablet, Extended-release tablet | Tablet, Modified-release tablet |
| Common side effects | Low blood sugar, Weight gain, Nausea | Low blood sugar, Weight gain, Stomach upset |
| Serious side effects | Severe hypoglycaemia, Liver injury, Blood-count abnormalities | Severe hypoglycaemia, Liver or blood problems (rare) |
| Don't take if | — | Type 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazole |
| Alcohol | — | Best to limit. Alcohol raises the risk of severe low blood sugar. |
| Pregnancy | Use with cautionInsulin is usually preferred when medicine is needed during pregnancy. | Usually avoidedUsually switched to insulin or metformin. |
| Breastfeeding | — | Usually avoidedAvoid; insulin preferred. |
| In use since | — | 1972 |
| Brand names | United States: Glucotrol, Glucotrol XL | United Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MR |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BB07 | A10BB09 |
Taken together
- MinorGlipizide + Gliclazide: More risk of low blood sugar
Both medicines lower blood sugar; combinations are common but hypos become more likely.